Coloplast A/S (OTCMKTS:CLPBY) Reaches New 52-Week Low – Here’s Why

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) hit a new 52-week low during trading on Tuesday . The stock traded as low as $5.65 and last traded at $5.71, with a volume of 563905 shares traded. The stock had previously closed at $5.75.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the stock. The Goldman Sachs Group lowered shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a research note on Tuesday, April 7th. Kepler Capital Markets raised shares of Coloplast A/S to a “strong-buy” rating in a research note on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold”.

Coloplast A/S Stock Down 0.7%

The company has a market capitalization of $12.87 billion, a P/E ratio of 40.79, a price-to-earnings-growth ratio of 1.82 and a beta of 0.18. The company has a 50-day moving average of $6.27 and a two-hundred day moving average of $7.34. The company has a quick ratio of 0.81, a current ratio of 1.30 and a debt-to-equity ratio of 1.50.

Coloplast A/S (OTCMKTS:CLPBY) last posted its quarterly earnings data on Tuesday, May 12th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. The business had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.11 billion. Coloplast A/S had a return on equity of 31.96% and a net margin of 7.46%. On average, research analysts predict that Coloplast A/S Sponsored ADR will post 0.4 EPS for the current year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.